SCHEMBL8273233

SCHEMBL8273233

CC#CCn1c(N(C)CCN)nc2c1c(=O)n(Cc1ccc3ncccc3n1)c(=O)n2C

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 17/20 0.51
FAP Q12884 8/20 0.51
POU2F2 P09086 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
CHRM1 P11229 1/20 0.38
POU2F1 P14859 1/20 0.38
CHRM3 P20309 1/20 0.38
HRH2 P25021 1/20 0.38
MC4R P32245 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
GHSR Q92847 1/20 0.38
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13955212 0.90 DPP4 (0.40) DPP4FAPADORA3HTTHSD17B10
SCHEMBL4476399 0.89 DPP4 (0.48) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL8273228 0.89 DPP4 (0.48) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL4468648 0.89 DPP4 (0.48) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL8271571 0.89 DPP4 (0.49) DPP4FAPCHRM1HTTHSD17B10
SCHEMBL8272342 0.87 DPP4 (0.51) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL8273216 0.85 DPP4 (0.46) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL13936241 0.84 DPP4 (0.48) DPP4FAPPOU2F2ADORA3CHRM1
SCHEMBL8273204 0.84 DPP4 (0.45) DPP4FAPCHRM1DPP9HTT
SCHEMBL3917633 0.83 DPP4 (0.54) DPP4FAPPOU2F2ADORA3CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797093-B1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2012-05-30 EP disclosed
US-7495002-B2 3-methyl-7-butinyl-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 US disclosed
WO-2006029769-A1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-03-23 WO disclosed